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Oct-4: The Almighty POUripotent 
Regulator?
William Buitrago1 and Dennis R. Roop1,2
Oct-4 plays an essential role as a central regulator of the undifferentiated state. 
Grinnell et al. demonstrate for the first time that Oct-4 by itself has the ability to 
reprogram committed somatic cells, inducing their dedifferentiation by reverting 
them to a more developmentally potent state. This study provides evidence that 
Oct-4 might be the master regulator of the pluripotent state in mammalian cells.
Journal of Investigative Dermatology (2007) 127, 260–262. doi:10.1038/sj.jid.5700654
Embryonic stem (ES) cells possess a vast 
developmental potential that allows 
them to self-renew and give rise to any 
cell type within an organism (that is, 
they are pluripotent). Somatic stem cells 
are undifferentiated cells found among 
differentiated cells of a specific tissue 
and are considered to be multipotent. 
If we understood more about the biol-
ogy of stem cells, it would be possible 
to isolate, grow, and manipulate them in 
order to generate specific tissues, such 
as muscle, heart, lung, or kidney, which 
could be used to repair damaged and 
diseased organs. It is widely accepted 
that ES cells have a greater developmen-
tal potential than somatic stem cells, 
making them an attractive research tar-
get in regenerative medicine. However, 
the use of ES cells remains under heated 
ethical debate, and the use of somatic 
stem cells is hampered by the inabil-
ity to isolate a large pure population of 
these cells in many tissues.
In a recent landmark study, Takahashi 
and Yamanaka (2006) showed that 
induced expression of certain ES cell-
specific transcription factors in somatic 
cells is capable of reprogramming them 
into a more ES cell-like state. By using a 
clever and rational approach, they were 
able to identify four genes, Oct-4, Sox-
2, c-Myc, and Klf4, that can orchestrate 
reprogramming to a pluripotent state 
when simultaneously introduced into 
mouse embryonic and adult fibroblasts. 
However, the study by Grinnell et al. 
(2007, this issue) provides the first exam-
ple of the reprogramming of committed 
somatic cells to a more ES cell-like state 
with the use of a single factor. In particu-
lar, the authors demonstrate that transient 
transfection of Oct-4 into mouse interfol-
licular epidermal basal keratinocytes has 
the ability to endow the cells with prop-
erties characteristic of more develop-
mentally potent cells. For example, the 
Oct-4-transfected keratinocytes express a 
group of genes important for self-renewal 
and maintenance of the undifferentiated 
state in stem cells. Furthermore, the Oct-
4-transfected keratinocytes are capable 
of differentiating into a different cell type 
(that is, a neuronal cell type not found 
in the skin) when exposed to the appro-
priate culture conditions. The findings 
from these two studies are of paramount 
importance for therapeutic cell and/or 
tissue replacement applications, because 
they suggest that we could generate plu-
ripotent cells from committed somatic 
cells derived from readily accessible 
adult tissues such as the skin.
Oct-4 is a mammalian POU fam-
ily transcription factor that is normally 
expressed in ES cells, maintaining them 
in an immature state (Pesce and Scholer, 
2001). Oct-4 has also been shown to 
be expressed in germ cells and to be 
required for their pluripotency (Nichols et 
al., 1998; Niwa et al., 2000). Loss of Oct-
4 expression allows ES cells to differenti-
ate into different cell fates. For example, 
during the development of keratinocytes 
from cultured human ES cells (Green et 
al., 2003), loss of Oct-4 expression coin-
cides with the appearance of p63, a tran-
scription factor required for the estab-
lishment of the keratinocyte cell fate 
(Koster et al., 2004). In addition, previ-
ous reports have detected Oct-4 expres-
sion in germ-cell tumors (Gidekel et al., 
2003; Looijenga et al., 2003). More sur-
prisingly, Oct-4 expression has recently 
been detected in somatic-cell tumors 
(reviewed in Hochedlinger et al., 2005), 
which suggests that reactivation of Oct-4 
expression may also be associated with 
the formation and maintenance of tumor 
stem cells.
It is well established that Oct-4 down-
regulation is associated with ES cell 
differentiation. On the other hand, it 
has been previously demonstrated that 
concomitant Oct-4 reactivation and 
reprogramming occur in somatic cells 
after cell fusion with ES cells (Tada et 
al., 2001; Kimura et al., 2004), or after 
nuclear transfer into oocytes (Boiani et 
al., 2002; Bortvin et al., 2003). In addi-
tion, Shimazaki et al. (1993) showed that 
re-expression of Oct-4 is associated with 
dedifferentiation in hybrid-cell experi-
ments. However, none of these studies 
showed whether reprogramming and 
dedifferentiation occur as a result of Oct-
4 activity.
Grinnell et al. (2007) report that tran-
sient transfection of mouse epidermal 
interfollicular basal keratinocytes with 
mouse Oct-4 leads to nuclear local-
ization of the transcription factor and 
a temporally regulated expression 
pattern mimicking the Oct-4 expres-
sion pattern seen during embryonic 
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development. The expression of Oct-
4 peaks at 48 hours, and it is almost 
totally downregulated between 120 and 
168 hours after transfection. Oct-4 is a 
dose-dependent determinant of pluripo-
tency in ES cells. Therefore, the authors 
monitored gene expression and protein-
level changes in the transfected keratino-
cytes that were associated with different 
levels of Oct-4 expression.
Oct-4 orchestrates a relatively defined 
expression profile characteristic of the 
pluripotent state. Therefore, Grinnell 
et al. (2007) hypothesized that if Oct-
4 induced dedifferentiation of mature 
keratinocytes, reverting them to a more 
ES cell-like state, the expression profile 
would change as this process occurred. 
They showed that Oct-4 induced expres-
sion of ES cell genes in mouse epider-
mal interfollicular basal keratinocytes. 
Specifically, they showed that Oct-4 was 
capable of reactivating the expression of 
Sox-2, Utf1, Rex-1, and Nanog, which are 
early developmental genes under direct 
Oct-4 regulation in pluripotent ES cells. 
Interestingly, the expression of Utf1 and 
Rex-1 was still maintained even after Oct-
4 expression was downregulated. The 
expression of Sox-2, which is a cofactor 
of Oct-4, was temporally similar to that 
of Oct-4 and Nanog. The regulation and 
maintenance of the pluripotent state are 
areas of intense research, and it is clear 
that Oct-4 and Nanog are key regulators 
in these processes. The observations put 
forth by Grinnell et al. (2007) are of sig-
nificant importance because they show 
that in keratinocytes, and probably in 
other differentiated somatic cells, Oct-4 
has the ability to induce expression of 
ES cell genes by itself, suggesting that 
Oct-4 is at the cusp of the pluripotent 
signaling cascade. However, in a recent 
study, Loh et al. (2006) presented exten-
sive and convincing binding and genetic 
evidence showing that Nanog regulates 
the expression of Oct-4 and Sox-2 in 
mouse ES cells. It is possible that there 
exist cell-specific differences in the plu-
ripotent state, or that there are built-in 
redundant mechanisms that control this 
state, as indicated by the inability of Oct-
4 by itself to induce the pluripotent state 
in mouse embryonic or adult fibroblasts 
(Takahashi and Yamanaka, 2006). Further 
studies are warranted to clarify these 
issues in different cell types and species. 
Nevertheless, a clearer picture is emerg-
ing in which Oct-4, Nanog, and Sox-2 
are key regulators of the pluripotent state 
(Figure 1).
Not only is Oct-4 capable of inducing 
an ES cell-like expression profile, it is also 
capable of increasing the developmental 
potency of mouse keratinocytes. Indeed, 
Grinnell et al. (2007) showed that Oct-
4 expression allows mouse keratino-
cytes to achieve a neuronal phenotype 
and acquire a different gene expression 
profile in response to neuroectodermal 
growth conditions. The Oct-4-transfect-
ed keratinocytes expressed the neuronal 
markers nestin, neuN, and Sox-1 after 
culture in neuroectodermal medium.
This study has broad implications for 
the field of cell biology and regenera-
tive medicine. It shows for the first time 
that a single factor is capable of induc-
ing dedifferentiation of mature somatic 
cells. Also, it suggests that Oct-4 is the 
master regulator of the pluripotent state, 
as its transient expression is capable of 
increasing the developmental potential of 
lineage-committed somatic cells (that is, 
inducing the dedifferentiation of mouse 
keratinocytes). The idea of increasing the 
potency of differentiated somatic cells 
opens the possibility of developing a vast 
array of cell and tissue replacement ther-
apy applications. Needless to say, these 
possibilities must be explored on a tis-
sue- and species-specific basis, because 
it is possible that human cells and tissues 
will respond differently.
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Human Keratinocyte Toll-like 
Receptors Promote Distinct Immune 
Responses
Lloyd S. Miller1 and Robert L. Modlin1,2
It has been well established that Toll-like receptors (TLRs) are expressed by kera-
tinocytes and respond to their respective ligands to initiate immune responses. 
However, it appears that keratinocytes, via differential activation of TLRs, may play 
a key role in determining the type of subsequent cutaneous immune response 
generated against a particular pathogen.
Journal of Investigative Dermatology (2007) 127, 262–263. doi:10.1038/sj.jid.5700559
Human Toll-like receptors (TLRs, num-
bered 1–10) are found on a variety of 
different cell types and can recognize 
various components of microorgan-
isms, subsequently initiating signaling 
pathways important in the generation 
of cytokines, chemokines, antimicrobial 
peptides, and upregulation of adhesion 
and costimulatory molecules involved in 
innate and acquired immune responses 
(Kaisho and Akira, 2006). Previous stud-
ies have demonstrated that human kera-
tinocytes express TLRs 1–6 and 9 (Kawai 
et al., 2002; Mempel et al., 2003; Song 
et al., 2002; Pivarcsi et al., 2003; Baker 
et al., 2003; Miller et al., 2005; Kollisch 
et al., 2005). In addition, some of these 
studies have demonstrated that TLRs 
on keratinocytes are functional and 
respond to their respective ligands to 
produce cytokines, and chemokines, 
and to activate NF-κB. For example, 
several studies have reported that TLR2 
and TLR4 are expressed by human kera-
tinocytes and can be activated by their 
ligands, bacterial lipopeptides and lipo-
polysaccharide, respectively (Kawai et 
al., 2002; Mempel et al., 2003; Song et 
al., 2002; Pivarcsi et al., 2003; Kollisch 
et al., 2005). Furthermore, additional 
studies have demonstrated that TLR3 
and TLR5 are also expressed by human 
keratinocytes and can be activated by 
their ligands, double-stranded RNA 
(poly-I:C) and bacterial flagellin, respec-
tively (Dai et al., 2006; Baker et al., 
2003; Miller et al., 2005; Kollisch et al., 
2005). Lastly, previous studies have also 
identified that human keratinocytes 
express TLR9 and can respond to CpG 
motifs of bacterial DNA (Mempel et al., 
2003; Miller et al., 2005).
Lebre et al. (2007, this issue) confirm 
previous reports demonstrating that 
human keratinocytes express certain 
TLRs, including TLRs 1–6, 9, and 10. A 
particular strength of this study is that 
the authors evaluated TLR expression 
and activation on cutaneous keratino-
cytes derived from plastic surgery skin 
specimens and not mucosa-derived 
keratinocytes from human foreskin 
specimens. Taken together, these data 
provide additional evidence that kera-
tinocytes not only act as a barrier to 
infectious microorganisms but also 
detect components of these organisms 
and initiate immune responses via acti-
vation of TLRs. However, the authors 
also demonstrate that certain immune 
responses generated by activation of 
TLRs 3, 4, 5, and 9 on keratinocytes are 
indeed distinct (summarized in Table 
1). Although activation of TLRs 3, 4, 
5, and 9 all induced expression of the 
proinflammatory cytokine tumor necro-
sis factor-α, the neutrophil chemotac-
tic factor IL-8 (CXCL8), the monocyte 
and basophil chemokine CCL2, and 
macrophage inflammatory protein-3 
(CCL20), of particular interest was the 
differential production of chemokines 
by these TLRs. Activation of TLR3 and 
TLR5 selectively induced CCL27, a 
chemokine that promotes memory T-
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TLRs on keratinocytes 
may participate in 
immune responses and 
host defense against 
viruses and bacteria.
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